Technological Advancements in Monoclonal Antibodies

Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. The approval of biosimilar products has become a complex and balanced process, and there are versions of drugs with established biosimilarity that can offer a more acces...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos-Neto, José F., Oliveira, Fabricia O., Hodel, Katharine V. S., Fonseca, Larissa M. S., Badaró, Roberto, Machado, Bruna A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892242/
https://www.ncbi.nlm.nih.gov/pubmed/33628140
http://dx.doi.org/10.1155/2021/6663708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892242/
https://www.ncbi.nlm.nih.gov/pubmed/33628140
http://dx.doi.org/10.1155/2021/6663708

Ejemplares similares